Apyx Medical Corp

APYX is the ticker symbol for Apyx Medical Corp, a publicly traded US company.

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

Key metrics include a return on equity of -16.4%, a debt-to-equity ratio of 3.89.

The company reports trailing twelve-month revenue of $8.29M and net loss of $2.11M.

FINOTAUR aggregates real-time and fundamental data on APYX to help traders and investors make informed decisions. Track APYX in your trading journal alongside other positions for a unified view of your portfolio.